Pilot Study on the Safety of Daily Disposable Contact Lenses with Opaque Non-Refractive Features for Managing Myopia in Children: A Randomized Trial

By
Ravi C. Bakaraju
Jennie Diec
Daniel Tilia
Klaus Ehrmann
Ranjay Chakraborty
April 22, 2026
0 min

Overview

This pilot study evaluates the safety and feasibility of a daily disposable contact lens with opaque features designed for myopia management in children. Results indicate no adverse effects on eye growth, supporting further research into its efficacy.

Background

Myopia is a growing concern in pediatric populations, necessitating effective management strategies to slow its progression. Traditional optical methods often involve complex designs that may not be suitable for all children. This study introduces a novel lens design aimed at modifying retinal luminance without inducing defocus, highlighting the need for safety data before larger efficacy trials.

Data Highlights

Parameter	Results
Participants	7 enrolled, 6 completed
Axial Length Changes	Heterogeneous trajectories observed
Slit-lamp Findings	No adverse events reported
High-Contrast Visual Acuity	Stable throughout the study
Comfort Level	Generally acceptable

Key Findings

The study involved 7 children aged 7–15 years, with 6 completing the trial.
No vision-threatening adverse events or significant changes in visual acuity were observed.
Axial-length trajectories varied among participants, with some showing reduced elongation with the test lens.
Comfort levels for the lenses were reported as generally acceptable by participants.
The study design controlled for various confounding factors, isolating the effects of lens design.

Clinical Implications

The findings suggest that the tested contact lenses are safe for use in children with myopia, with no exacerbation of eye growth observed. Clinicians may consider these lenses as a potential option for myopia management in pediatric patients.

Conclusion

This pilot study provides preliminary evidence supporting the safety of daily disposable contact lenses with opaque features for myopia management in children, warranting further investigation in larger trials.